Aegis Capital Initiates Coverage On Auxilium Pharmaceuticals, Favors Acquisition

By: via Benzinga
In a report released Thursday, Aegis Capital analyst Raghuram Selvaraju initiated coverage on Auxilium Pharmaceuticals (NASDAQ: AUXL) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.